* Inari Medical Inc NARI.OQ reported a quarterly adjusted
loss
of 11 cents per share for the quarter ended in December. The
mean expectation of eight analysts for the quarter was for a
loss of 17 cents per share.
* Revenue rose 29.5% to $107.77 million from a year ago;
analysts
expected $104.84 million.
* Inari Medical Inc's reported EPS for the quarter was a
loss
of 11 cents.
* The mean earnings estimate of analysts had fallen by
about 1.5%
in the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* Inari Medical Inc shares had fallen by 11.3% this quarter.
* The company reported a quarterly loss of $5.8 million.
* Wall Street's median 12-month price target for Inari
Medical Inc
is $95.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data February
27 at 10:03 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.17 -0.11 Beat
Sep. 30 2022 -0.25 -0.19 Beat
Jun. 30 2022 -0.23 -0.19 Beat
Mar. 31 2022 -0.09 -0.06 Beat